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In the last years severe efforts turned into extensive research on
development of novel antimicrobial compounds. Among them,
antimicrobial peptides, commonly isolated from several organ-
isms, have been considered part of innate immune system and
also as potential antimicrobial drugs. AMPs have variable amino
acid composition and size (ranging from less than 5–100 amino
acid residues), commonly showing cationic and amphipathic
properties. Nowadays about 2300 AMPs have been reported
in the Antimicrobial Peptide Database (AMP database). Such
research endeavor resulted in more than 100 peptide-based drugs
available in the market with approximately 500–600 candidates
in pre-clinical test development (Craik et al., 2013). Therefore
the current issue encloses several aspects when studying within
antimicrobial peptides field.
Besides its antimicrobial activity, some AMPs also have anti-
fungal activity, inmmunomodulatory and antitumural activities.
For example defensins commonly found in plants, fungi, insect
and mammalian cells are small cationic peptides of 45–54 amino
acid residues with a conserved signature of cysteines, which can
form three to four disulfide bridges. Those have been shown
to have inmmunomodulatory activities that can be used as vac-
cine adjuvants or in the treatment of immune-depressed patients.
Therefore, a better understanding of function and mechanism of
action of such molecules is a great promise in anti-infective and
immunomodulatory therapeutics (Silva et al., 2014).
Defensins isolated from plants also have been considered as
a biotechnological tool to improve crop production as recently
reviewed (Lacerda et al., 2014). Among their advantages low
effective fungicide concentrations and decreased environmental
impact have been focused when compared to most common
chemicals utilized for fungi control. Therefore many studies have
focused in construction of genetic modified plants that over pro-
duce such molecules in order to reduce crop losses by fungi
infection. Nevertheless it is important to emphasize that although
there are many studies occurring at bench scale, indicating that
genetic modified plants over producing defensins should appear
in the market within the next years (Lacerda et al., not published).
It is also know that antimicrobial peptides have other poten-
tial applications since some of them have also antitumoral and
imunomodulator activities. Also know as anticancer peptides
(ACP) and host defense peptides (HDP) they also represent
important candidates as novel drugs and have been carefully
addressed in the current issue. For instance, cationic peptides
have been considered as anticancer agents for presenting numer-
ous advantages over chemical agents such as higher specific
cytotoxicity to tumor cells, lower side effects and easier absorp-
tion as recently listed (Mulder et al., 2013). Diverse studies have
shown that cancer cells are more anionic than normal cells. Due
this property, cationic AMPs seems to bind it faster and selectively
resulting in cell death. A better understanding of ACP mecha-
nism of action may result in novel pharmacies with optimized
anticancer activity (Gaspar et al., 2013).
Despite the great number of peptides available in databases,
isolation of new molecules using classic purification techniques is
crucial to identify novel molecules with diverse activities. Indeed
a proteinase inhibitor isolated from J. curcas seed cake, named
JcTI-I, was shown to have a potent activity against the human
pathogenic bacteria S. aureus and S. enterica. Moreover it did
present other relevant pharmacologically characteristics such as
absence of hemolytic activity against human erythrocytes con-
comitant to pH and high salt concentration resistance (Costa
et al., 2014). Moreover, microorganism have also been focused
in this issue were the isolation and characterization of lipopep-
tide from Bacillus sp. were performed. This lipopetide shows
strong fungicide activity (specially when this compound was
self-assembled) (Roy et al., 2013).
Lately not only nature has become a source of AMPs. Besides
isolation of natural organisms, antimicrobial peptides might
be improved or created using computational tools. This opens
even more this so amazing field by creating infinite novel and
remarkable possibilities. Recently a study screened the distribu-
tion of known motifs in prokaryotic extracellular and virulence
proteins across a range of bacterial species in order to iden-
tify novel motifs in virulence proteins (Ruhanen et al., 2014).
Such methodologies are able to generate thousands of novel
molecules that require high-throughput in vitro and in vivo
validation. In this sense it is also necessary to develop rapid
assays that can be performed concomitant to million candi-
dates. A recent method enabled the selection of AMPs directly
on peptide microarrays allowing identification of AMPs that
bind and are bactericide among those that bind but do not
kill bacteria (Wimley, 2010). In another example, an affin-
ity support might be applied for the isolation of AMPs that
interact with lipopolysaccharides, the major cause of septic
shock (Lopez-Abarrategui et al., 2013). Thus advances in pep-
tide array discovery assays could provide a system to develop
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pathogen-specific antibiotics resulting in the discovery of target
antibiotics (Diehnelt, 2013).
In alignment with in silico models, several systemic strate-
gies such as transcriptome and proteome have been utilized for
understanding peptide interaction with its target, which may
allow improvement or design new molecule properties (Tavares
et al., 2013). These novel approaches could lead us to under-
stand several compounds at the same time which may result in
a rapid increased in AMP peptides available in the market for
treating several diseases. Finally it is fundamental to understand
mechanism of action of AMPs in order to improve its activ-
ity and predict possible resistance mechanisms. Although many
AMP alters membrane permeability there are other actionmecha-
nisms such as synthesis inhibition of cell wall, protein synthesis or
nucleic acids as reviewed in this issue (Guilhelmelli et al., 2013).
Moreover it is also essential to clear elucidate host-pathogen
relationship. A recent study hypothesized that Helmint defense
peptides played a critical role in parasite interaction with its host
(Robinson et al., 2013). This may be applied as immunomodula-
tors agents since those molecules are able to interact with the host
without cytotoxic or cytolytic effects.
Overall the current issue highlights the relevance of such
research topic with perspectives to develop entirely newmolecules
with vast application within health and agricultural field with c
higher affinity for its target with concomitant reduction of side
effects.
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